Condition: Hemorrhagic Shock · Trauma Injury · Sponsor: Philip Spinella
The MATIC-2 is a multicenter clinical trial enrolling children who are less than 18 years of age with hemorrhagic shock potentially needing significant blood transfusion. The primary objective of the clinical trial is to determine the effectiveness of Low Titer Group O Whole Blood (LTOWB) compared to component therapy (CT), and Tranexamic Acid (TXA) compared to placebo in decreasing 24-hour all-cause mortality in children with traumatic life threatening hemorrhage.
This description comes directly from the study's public registry record.
Thomas Byers · 412-383-2340 · tdb33@pitt.edu
Always discuss trial participation with your own doctor first.
| University of Arizona | Tucson, Arizona, United States | Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Recruiting |
| University of California Davis | Sacramento, California, United States | Recruiting |
| Children's National Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Emory University-Arthur M. Blank Hospital | Atlanta, Georgia, United States | Recruiting |
| Emory University-Scottish Rite Hospital | Atlanta, Georgia, United States | Terminated |
| Tulane School of Medicine | New Orleans, Louisiana, United States | Withdrawn |
| University of Mississippi Medical Center | Jackson, Mississippi, United States | Recruiting |
| Washington University of St. Louis | St Louis, Missouri, United States | Recruiting |
| University of New Mexico | Albuquerque, New Mexico, United States | Recruiting |
| Wake Forest University Health Sciences | Wake Forest, North Carolina, United States | Recruiting |
| Nationwide Children's Hospital | Columbus, Ohio, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06070350